Alright, alright, alright: Arrhythmogenic Right Ventricular Cardiomyopathy

    NextPrevious

    Alright, alright, alright: Arrhythmogenic Right Ventricular Cardiomyopathy

    When you examine the ECG of a patient who syncopized, what are you looking for? You’re probably checking for a prolonged QT interval, signs of left ventricular hypertrophy consistent with hypertrophic obstructive cardiomyopathy, a delta wave consistent with Wolff-Parkinson-White syndrome, and T-waves suggestive of Brugada syndrome. But is arrhythmogenic right ventricular cardiomyopathy (ARVC) on your differential?

     

    Epidemiology

    The prevalence of ARVC in the general population is 1 in 5000, but in some European populations, it reaches 1 in 2000. It is inherited in an autosomal dominant manner, but penetrance and expression are variable, so patients may lack an obvious family history. It is the second-most common cause of sudden cardiac death (SCD) in young people (after HOCM), and depending on prevalence in the studied population, may be responsible for up to 20% of SCD in patients under 35 years old.

     

    Pathophysiology

    The pathophysiology of ARVC on the cellular level remains unclear, but may be caused by disruption of intercellular junctions in the myocardium. Myocyte separation may cause cell death, which increases afterload and wall stress. Structurally, myocardium is replaced by fibrofatty tissue. The fibrofatty tissue slows intraventricular conduction, predisposing patients to life-threatening ventricular arrhythmias.

     

    Signs and symptoms

    ARVC is clinically silent in childhood, and does not become symptomatic until a patient is in their 20s-40s. Unfortunately, SCD may be the first clinical manifestation. However, palpitations or syncope after physical exertion are more common presentations. These patients have ECG changes, including T-wave inversions in leads V1 through V4 and an epsilon wave – a small, positive deflection at the end of the QRS complex. While the epsilon wave is the most specific ECG finding for ARVC, it is only seen in 30% of patients.

    Diagnosis

    If a patient has a concerning clinical history and ECG, use imaging to confirm the diagnosis. While many patients may receive echocardiography first, cardiac MRI is more sensitive and the modality of choice.

     

    Treatment

    All patients with ARVC should avoid physical exertion, which may precipitate arrhythmias. Any patient who has been clinically symptomatic should start beta-blocker therapy. Patients who have experienced arrhythmias may consider adding amiodarone or sotalol. Patients who have had an episode of ventricular fibrillation or ventricular tachycardia should get an ICD.

     

    References

    1. Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376(1):61-72.
    2. Burns E. Arrhythmogenic right ventricular cardiomyopathy. http://lifeinthefastlane.com/ecg-library/basics/arrhythmogenic-right-ventricular-cardiomyopathy/.

     

    • Welcome! This is the website for the Mount Sinai Emergency Ultrasound Division. It serves as an information resource for residents, fellows, medical students and others seeking information about point-of-care ultrasound. There is a lot ofRead more

    • renal handling of water

      If you were on a tea & toast diet, how much water would you need to drink before you develop hyponatremia? I haven’t seen anyone work out the numbers before so here are my calculations. AndRead more

    • acute acidemia physiology

      As alluded to in the first post, don’t be fooled by a “normal” potassium in the setting of DKA because osmotic diuresis and H+/K+ exchange means that total body potassium is actually LOW. You all knowRead more

    • renal handling of potassium

      the first symptom of hyperkalemia is death Earlier post covered temporizing measures to counter hyperkalemia — namely, intracellular shift, increasing cardiac myocyte threshold potential. Give furosemide if the patient still urinates and consider dialysis, but then askRead more

    • bicarbonate revisited

      Previous post reviewed the safety of balanced crystalloids in hyper K. But what was up with serum bicarbonate decreasing with saline administration? This post introduces a new way of looking at the anion gap to possiblyRead more

    • hyperkalemia and balanced crystalloids

      Is it safe to give LR or plasmalyte to a hyperkalemic patient (these balanced crystalloids have 4-5 mEq/L K as opposed to 0 mEq/L K in normal saline)? Postponing the discussion of renal handling of potassium toRead more

    • hyperkalemia physiology

      You’ll likely encounter hyperkalemia on your next Resus / Cardiac shift, and you’ll instinctively treat it. But take a moment to review the fascinating physiology behind the “cocktail”! First, consider how K+ is buffered byRead more

    • Slow down your tachycardia (but not really)

      You’re sitting in resus bemoaning the departure of your most beloved attending when suddenly a patient wheels in without warning. The patient looks relatively stable but the triage RN tells you her heart rate wasRead more

    • Otitis externa: use the ear wick!

      Acute otitis externa (AOE) is a common complaint seen in pediatric as well as adult emergency departments. AOE is typically not accompanied by acute otitis media, although concurrent cases are possible. Also called “swimmer’s ear”Read more

    NextPrevious